216 related articles for article (PubMed ID: 30029732)
1. Dehydroepiandrosterone (DHEA)-SO
Penning TM
Vitam Horm; 2018; 108():309-331. PubMed ID: 30029732
[TBL] [Abstract][Full Text] [Related]
2. The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.
Tamae D; Mostaghel E; Montgomery B; Nelson PS; Balk SP; Kantoff PW; Taplin ME; Penning TM
Chem Biol Interact; 2015 Jun; 234():332-8. PubMed ID: 25514466
[TBL] [Abstract][Full Text] [Related]
3. Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer.
Maity SN; Titus MA; Gyftaki R; Wu G; Lu JF; Ramachandran S; Li-Ning-Tapia EM; Logothetis CJ; Araujo JC; Efstathiou E
Sci Rep; 2016 Oct; 6():35354. PubMed ID: 27748439
[TBL] [Abstract][Full Text] [Related]
4. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.
Yamaoka M; Hara T; Hitaka T; Kaku T; Takeuchi T; Takahashi J; Asahi S; Miki H; Tasaka A; Kusaka M
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):115-28. PubMed ID: 22249003
[TBL] [Abstract][Full Text] [Related]
5. Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.
Li R; Evaul K; Sharma KK; Chang KH; Yoshimoto J; Liu J; Auchus RJ; Sharifi N
Clin Cancer Res; 2012 Jul; 18(13):3571-9. PubMed ID: 22753664
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids.
Rainey WE; Bird IM; Sawetawan C; Hanley NA; McCarthy JL; McGee EA; Wester R; Mason JI
J Clin Endocrinol Metab; 1993 Sep; 77(3):731-7. PubMed ID: 8396576
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue.
Dalla Valle L; Toffolo V; Nardi A; Fiore C; Bernante P; Di Liddo R; Parnigotto PP; Colombo L
J Endocrinol; 2006 Jul; 190(1):129-39. PubMed ID: 16837617
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of resistance to CYP17A1 inhibitors in castrate resistant prostate cancer].
Ripert T; Crouzet S; Ploussard G; De La Taille A; Robert G
Prog Urol; 2013 Oct; 23 Suppl 1():S16-22. PubMed ID: 24314735
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.
Mesiano S; Katz SL; Lee JY; Jaffe RB
J Clin Endocrinol Metab; 1997 May; 82(5):1390-6. PubMed ID: 9141522
[TBL] [Abstract][Full Text] [Related]
10. CYP17A1-independent production of the neurosteroid-derived 5α-pregnan-3β,6α-diol-20-one in androgen-responsive prostate cancer cell lines under serum starvation and inhibition by Abiraterone.
de Mello Martins AGG; Allegretta G; Unteregger G; Haupenthal J; Eberhard J; Hoffmann M; van der Zee JA; Junker K; Stöckle M; Müller R; Hartmann RW; Ohlmann CH
J Steroid Biochem Mol Biol; 2017 Nov; 174():183-191. PubMed ID: 28890368
[TBL] [Abstract][Full Text] [Related]
11. Intracrinology-revisited and prostate cancer.
Penning TM; Detlefsen AJ
J Steroid Biochem Mol Biol; 2020 Feb; 196():105499. PubMed ID: 31614208
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the adrenal cytochrome P450C17 in the hamster, a small animal model for the study of adrenal dehydroepiandrosterone biosynthesis.
Cloutier M; Fleury A; Courtemanche J; Ducharme L; Mason JI; Lehoux JG
DNA Cell Biol; 1997 Mar; 16(3):357-68. PubMed ID: 9115645
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
14. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase.
Endoh A; Kristiansen SB; Casson PR; Buster JE; Hornsby PJ
J Clin Endocrinol Metab; 1996 Oct; 81(10):3558-65. PubMed ID: 8855801
[TBL] [Abstract][Full Text] [Related]
15. Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer.
Suzuki K; Sakamoto M; Terakawa T; Furukawa J; Harada K; Hinata N; Nakano Y; Fujisawa M
Anticancer Res; 2018 Oct; 38(10):5929-5935. PubMed ID: 30275221
[TBL] [Abstract][Full Text] [Related]
16. PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.
Yang Y; Bai Y; He Y; Zhao Y; Chen J; Ma L; Pan Y; Hinten M; Zhang J; Karnes RJ; Kohli M; Westendorf JJ; Li B; Zhu R; Huang H; Xu W
Clin Cancer Res; 2018 Feb; 24(4):834-846. PubMed ID: 29167276
[No Abstract] [Full Text] [Related]
17. Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus.
Ueshiba H; Shimizu Y; Hiroi N; Yakushiji F; Shimojo M; Tsuboi K; Miyachi Y
Eur J Endocrinol; 2002 Mar; 146(3):375-80. PubMed ID: 11888844
[TBL] [Abstract][Full Text] [Related]
18. 3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.
Evaul K; Li R; Papari-Zareei M; Auchus RJ; Sharifi N
Endocrinology; 2010 Aug; 151(8):3514-20. PubMed ID: 20534728
[TBL] [Abstract][Full Text] [Related]
19. CYP17A1 inhibitors in castration-resistant prostate cancer.
Gomez L; Kovac JR; Lamb DJ
Steroids; 2015 Mar; 95():80-7. PubMed ID: 25560485
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.
Xiao L; Wang Y; Xu K; Hu H; Xu Z; Wu D; Wang Z; You W; Ng CF; Yu S; Chan FL
Cancer Res; 2018 May; 78(9):2205-2218. PubMed ID: 29438990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
